Nocturnal patterns of growth hormone (GH) in obsessive compulsive disorder (OCD), which is physiologically released predominantly during the first half of night, have not been reported. However, altered GH responses to pharmacological challenges suggest a disturbed function of the somatotropic axis in OCD. In this study, nine inpatients with a DSM-IV diagnosis of OCD without comorbid major depression (Yale-Brown Obsessive Compulsive Scale (Y-BOCS) score >15; HAMD-21 total score 16) and 9 healthy matched controls were included. Blood of patients (7 males, 31.8+/-9.3 years, Y-BOCS: 27.3+/-4.3, HAMD-21: 13.3+/-1.9) and controls (7 males, 31.6+/-9.1 years) was drawn every 20 min between 2300 and 0700 h during sleep using a long catheter for later GH analysis. Mean plasma GH levels peaked at 0040 h, however this peak was significantly blunted in patients (maximum 4.3+/-1.5 ng/ml) compared to controls (maximum 12.3+/-4.0 ng/ml; p<0.05). In patients but not controls two other, smaller peaks were observed (0220 and 0620 h). In patients but not in controls, GH values exceeding maximum GH values of the peak at 0040 h were observed already at 2300 h or during the second half of night. In conclusion, our results indicate that the nocturnal GH secretion in patients with OCD is altered compared to controls.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.psyneuen.2006.07.002 | DOI Listing |
Psychiatr Clin North Am
March 2025
Harvard University, Boston Children's Hospital, Tic Disorders and Tourette Syndrome Program, Department of Neurology, 300 Longwood Avenue, Boston, MA 02115, USA. Electronic address:
Repetitive behaviors are the hallmark of many neuropsychiatric disorders, including Tourette syndrome (TS), obsessive-compulsive disorder (OCD), and autism spectrum disorder (ASD). Tics, compulsions, and stereotypies may appear similar and can be difficult to disentangle. This review addresses similarities and differences between these behaviors including clinical presentations, neuroimaging, genetics, and treatment paradigms in order to clarify the relationship between these disorders.
View Article and Find Full Text PDFJ Behav Ther Exp Psychiatry
January 2025
New York State Psychiatric Institute/Columbia Psychiatry, USA; Columbia Psychiatry, Columbia University Medical Center, USA.
Background: Cross-sectional studies have reported neurocognitive performance deficits in obsessive-compulsive disorder (OCD), particularly on tasks assessing response inhibition and proactive control over stimulus-driven behaviors (task control). However, it is not clear whether these deficits represent trait-like markers of OCD or are state-dependent.
Methods: This study examined performance on two neurocognitive tasks in OCD patients (N = 26) before and after cognitive behavioral therapy (CBT) and matched healthy controls (HCs, N = 19).
Naunyn Schmiedebergs Arch Pharmacol
January 2025
Graduate School of PLA Medical College, Chinese PLA General Hospital and PLA Medical College, 28 Fu Xing Road, Beijing, 100083, China.
Extensive researches illuminate a potential interplay between immune traits and psychiatric disorders. However, whether there is the causal relationship between the two remains an unresolved question. We conducted a two-sample bidirectional mendelian randomization by utilizing summary data of 731 immune cell traits from genome-wide association studies (GCST90001391-GCST90002121)) and 11 psychiatric disorders including attention deficit/hyperactivity disorder (ADHD), anxiety disorder, autism spectrum disorder (ASD), bipolar disorder (BIP), anorexia nervosa (AN), major depressive disorder (MDD), obsessive-compulsive disorder (OCD), Tourette syndrome (TS), post-traumatic stress disorder (PTSD), schizophrenia (SCZ), and substance use disorders (cannabis) (SUD) from the Psychiatric Genomics Consortium (PGC).
View Article and Find Full Text PDFCurr Drug Saf
January 2025
Department of Pharmacology, Government Medical College, Bhavnagar, India.
Background: Clomipramine, a Tricyclic Antidepressant (TCA), is known for its efficacy in treating Obsessive-compulsive Disorder (OCD). However, it is associated with several side effects, including urinary retention. This case report discusses the case of a 20-year-old male with OCD who developed urinary retention following clomipramine administration.
View Article and Find Full Text PDFAm J Psychiatry
January 2025
Nathan Kline Institute for Psychiatric Research, Orangeburg, NY (Stern, Collins, Bragdon, Eng, Recchia, Tobe, Iosifescu); Department of Psychiatry (Stern, Bragdon, Eng, Recchia, Iosifescu) and Neuroscience Institute (Stern, Iosifescu), New York University Langone Medical Center, New York; Department of Psychiatry, University of Miami Medical School, Miami (Coffey); Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York (Leibu, Murrough); Center for the Developing Brain, Child Mind Institute, New York (Tobe); Department of Psychiatry, Brigham and Women's Hospital, Boston (Burdick); Harvard Medical School, Boston (Burdick); Department of Psychiatry, Baylor College of Medicine, Houston (Goodman).
Objective: Sensory phenomena (SP) are aversive sensations driving repetitive behaviors in obsessive-compulsive disorder (OCD) and Tourette's disorder that are not well addressed by standard treatments. SP are related to the functioning of an interoceptive-sensorimotor circuit that may be modulated by the 5-HT receptor antagonist ondansetron. The present study employed an experimental medicine approach to test the effects of 4 weeks of high-dose ondansetron compared to placebo on SP severity and brain connectivity in a cohort of individuals with OCD and/or Tourette's disorder.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!